SAR444836
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for SAR444836, covering 2025-09-23 to 2025-09-23. Get the full timeline:
Most recent: Clinical Trial Update: A Phase 1/Phase 2 Open-label Study to Evaluate the Safety, Tolerability, and Efficacy of a Single Intravenous Administration of SAR444836 in Adult Participants With Phenylketonuria [Phase 1, Phase 2]